Plaque Stabilization & Restoration by Bioresorbable Vascular Scaffold

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The aim of the study is to assess if implantation of a bioresorbable vascular scaffold (BVS) for intermediate coronary lesions with morphological signs of vulnerable plaque in patients prone for acute coronary syndromes (ACS) will stabilize the plaque, improve natural vasomotion and increase vascular diameter.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05333068` - COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events	N/A

NCT number	NCT02319733
Study type	Interventional
Source	Canisius-Wilhelmina Hospital
Contact
Status	Terminated
Phase	N/A
Start date	December 2014
Completion date	January 2017

Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms